|
US2020325274A1
|
|
Tertiary alkoxy polyethylene glycol and derivatives thereof
|
|
KR101637883B1
|
|
Polyethylene glycol hydrogel injection
|
|
US2014155457A1
|
|
Method of Relieving, Improving, Preventing or Treating Xerostomia
|
|
KR20140072775A
|
|
Mouthwashes and pharmaceutical compositions comprising polyethylene glycol derivatives for preventing, treating, improving xerostomia
|
|
US2008159975A1
|
|
Hair treatment composition, hair treatment agent and method for treating hair by using the same
|
|
KR20080058134A
|
|
Hair treatment composition, hair treatment agent and method for treating hair by using the same
|
|
KR20060035343A
|
|
Hair coating composition comprising polyethylene glycol derivatives as an effective ingredient
|
|
KR20050097358A
|
|
Novel y-peg derivatives and the methods for preparing them
|
|
KR20050017774A
|
|
Novel Y-PEG Derivatives and the preparation method thereof
|
|
KR20040096016A
|
|
Novel Preparation method of PEG-maleimide PEG derivatives
|
|
KR20040040782A
|
|
Novel hexa-arm polyethylene glycol and its derivatives and the methods of preparation thereof
|
|
US2004072729A1
|
|
High oxygen affinity PEG-hemoglobin as treatment for brain stroke
|
|
KR20030056852A
|
|
A virus removal process in the purification of biologically active molecules
|
|
KR20030048293A
|
|
Novel polyethylene glycol-propionaldehyde derivatives
|
|
KR20030045413A
|
|
Conjugates of interferon-alpha and polyethylene glycol derivatives
|
|
KR20030045415A
|
|
Conjugates of granulocyte-colony stimulating factor and polyethylene glycol derivatives
|
|
KR20030045416A
|
|
Conjugates of erythropoietin and polyethylene glycol derivatives
|
|
KR20030045414A
|
|
Conjugates of interferon-beta and polyethylene glycol derivatives
|
|
KR20030037598A
|
|
Modified interferon-beta, and chemically modified conjugates thereof
|
|
KR20020089772A
|
|
Polyethylene glycol hydrogel for bioadhesive
|
